Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy

Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy

Show other versions (1)

Dasatinib is a kinase inhibitor indicated for the treatment of newly diagnosed adults with Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase and accelerated (myeloid or lymphoid blast) phase, and CML with resistance or intolerance to prior therapy including imati...

Full description

Bibliographic Details
Main Authors: Mohamed A. Yassin, Abdulqadir J. Nashwan, Ashraf T Soliman, Anil Yousif, Afra Moustafa, Afaf AlBattah, Shehab F. Mohamed, Deena S. Mudawi, Sarah Elkourashy, Deena-Raiza Asaari, Hope-Love G. Gutierrez, Mohamed Almusharaf, Radwa M. Hussein, Abbas H. Moustafa, Hatim El Derhoubi, Sarra Boukhris, Samah Kohla, Nader AlDewik
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Clinical Medicine Insights: Case Reports
Online Access:https://doi.org/10.4137/CCRep.S25327

Internet

https://doi.org/10.4137/CCRep.S25327

Similar Items